Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Gheuens Sarah sold 4,007 Agios Pharmaceuticals, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Gheuens Sarah (Chief Medical Officer) sold 4,007 Agios Pharmaceuticals, Inc. shares at US$37.56 for US$151K under a trading plan, leaving 84,645 shares. Filed Jul 2, 2026 (Form 4).

Sold
4,007 shares
Price
US$37.56
Value
US$151K
Holding after
84,645 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common stockOption exercise8,37588,652Direct
Jul 1, 2026Common stockSale4,007US$37.5684,645Direct

Source

View original at SEC

Related